These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4308492)

  • 121. Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 3. 2,7-Bis(aminoacyl)fluorenes and -fluorenones.
    Albrecht WL; Fleming RW; Horgan SW; Kihm JC; Mayer GD
    J Med Chem; 1974 Aug; 17(8):886-9. PubMed ID: 4367594
    [No Abstract]   [Full Text] [Related]  

  • 122. Antiviral action of rifampicin.
    Lancet; 1970 Feb; 1(7643):399. PubMed ID: 4189697
    [No Abstract]   [Full Text] [Related]  

  • 123. Some nuclear-substituted derivatives of alpha-methyldopa.
    Parulkar A; Burger A; Aures D
    J Med Chem; 1966 Sep; 9(5):738-41. PubMed ID: 4291024
    [No Abstract]   [Full Text] [Related]  

  • 124. The utility of the Rous sarcoma virus for detection of antiviral activity.
    JOHNSON IS; BAKER LA
    Antibiot Chemother (Northfield); 1958 Mar; 8(3):113-21. PubMed ID: 24544676
    [No Abstract]   [Full Text] [Related]  

  • 125. An antiviral substance from Penicillium funiculosum. IV. Inquiry into the mechanism by which helenine exerts its antiviral effect.
    Shope RE
    J Exp Med; 1966 Feb; 123(2):213-27. PubMed ID: 5905239
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 2. Tilorone and related bis-basic ethers of fluorenone, fluorenol, and fluorene.
    Andrews ER; Fleming RW; Grisar JM; Kihm JC; Wenstrup DL; Mayer GD
    J Med Chem; 1974 Aug; 17(8):882-6. PubMed ID: 4367593
    [No Abstract]   [Full Text] [Related]  

  • 127. Factors modifying host resistance to viral infection. I. Effect of immunosuppressive drugs on experimental infection of mice with encephalomyocarditis virus.
    Murphy BR; Glasgow LA
    Antimicrob Agents Chemother (Bethesda); 1967; 7():661-7. PubMed ID: 4299356
    [No Abstract]   [Full Text] [Related]  

  • 128. The antiviral action of phenanthridinium compounds.
    DICKINSON L; CHANTRILL BH; INKLEY GW; THOMPSON MJ
    Br J Pharmacol Chemother; 1953 Jun; 8(2):139-42. PubMed ID: 13066711
    [No Abstract]   [Full Text] [Related]  

  • 129. Failure of dimethylsulfoxide to enhance experimental viral infection in laboratory animals.
    Chan JC; Ullal I; Valand RS; Gadebusch HH
    Z Naturforsch B; 1969 Jan; 24(1):145-6. PubMed ID: 4388869
    [No Abstract]   [Full Text] [Related]  

  • 130. Studies on antiviral antibiotics from streptomyces. X. Effect of myxoviromycin upon infection with influenza virus in mice.
    HINUMA Y; SATO S; CHIBA M; KOSAKA Y; KUROYA M
    Jpn J Microbiol; 1958 Apr; 2(2):117-25. PubMed ID: 13575006
    [No Abstract]   [Full Text] [Related]  

  • 131. ANTI-VIRUS FOR LEUKAEMIA.
    MACLENNAN R
    Lancet; 1964 Nov; 2(7370):1163-4. PubMed ID: 14213583
    [No Abstract]   [Full Text] [Related]  

  • 132. Antiviral activity of herbs on Columbia SK in mice, and LSM, vaccinia and adeno type 12 viruses in vitro.
    Cutting W; Furusawa E; Furusawa S; Woo YK
    Proc Soc Exp Biol Med; 1965 Nov; 120(2):330-3. PubMed ID: 4285452
    [No Abstract]   [Full Text] [Related]  

  • 133. Alanosine, a new antiviral and antitumour agent isolated from a Streptomyces.
    Murthy YK; Thiemann JE; Coronelli C; Sensi P
    Nature; 1966 Sep; 211(5054):1198-9. PubMed ID: 5970033
    [No Abstract]   [Full Text] [Related]  

  • 134. [Inhibiting effects of new antibiotics 1212 and 452-7 on vaccinia virus].
    GERMANOVA KI; SAVEL'EVA AM
    Vopr Virusol; 1959; 4(3):348-53. PubMed ID: 13676474
    [No Abstract]   [Full Text] [Related]  

  • 135. The susceptibility of rats to encephalomyocarditis viruses.
    FINDLAY GM; HOWARD EM
    Br J Exp Pathol; 1951 Dec; 32(6):569-72. PubMed ID: 14895797
    [No Abstract]   [Full Text] [Related]  

  • 136. The effect of antibiotics upon the growth of sarcoma 180 in vivo.
    REILLY HC; STOCK CC; BUCKLEY SM; CLARK DA
    Cancer Res; 1953 Sep; 13(9):684-7. PubMed ID: 13094678
    [No Abstract]   [Full Text] [Related]  

  • 137. Nonspecific resistance of the organism and myxovirus inhibitors. Comparison of some antibacterial and antiviral mechanisms.
    BORECKY L; RATHOVA V; KRIZANOVA O
    Folia Microbiol (Praha); 1963 May; 8():137-46. PubMed ID: 14013895
    [No Abstract]   [Full Text] [Related]  

  • 138. Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing.
    Rammohan A
    World J Transplant; 2020 Sep; 10(9):267-276. PubMed ID: 32995321
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
    Perricone C; Triggianese P; Bartoloni E; Cafaro G; Bonifacio AF; Bursi R; Perricone R; Gerli R
    J Autoimmun; 2020 Jul; 111():102468. PubMed ID: 32317220
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity.
    Hsieh MS; Chen MY; Hsieh CH; Pan CH; Yu GY; Chen HW
    PLoS One; 2017; 12(11):e0188170. PubMed ID: 29161301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.